Strides Pharma Inc. is recalling 11,280 bottles of Potassium Chloride Extended-Release Tablets, USP 8mEq (600 mg) because the medication failed dissolution specifications. This prescription drug, used to treat low potassium levels, may not release the medication into the body at the correct rate. The recall affects 100-count bottles that were distributed nationwide throughout the United States.
If the tablets do not dissolve as intended, the medication may be released too quickly or too slowly, which can prevent the patient from maintaining proper potassium levels and potentially lead to serious electrolyte imbalances. No specific injuries or adverse events were reported in the recall notice.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.